Cinvanti savings card: up to $150 off a prescription without insurance

Cinvanti is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How to pay the least

Given by your care team

Billed by the clinic

Cinvanti is given by a doctor or nurse, not picked up at a pharmacy.

Ask your care team or your plan what you’d pay before your visit.

Compare every option

Brand nameCinvanti

Authorized genericaprepitant

Regular genericaprepitant

What you’d pay

Up to$150 offa prescription with the maker’s card

Not soldThere isn’t one

Not soldNone found

Same as Cinvanti?

The original

–

Brand nameThe maker’s card

Heron Connect Copay Assistance Program

Savings card from Heron Therapeutics

No insurance · up to $150 off a prescription

Insurance $0 a dose

The card takes up to $200 a treatment off your co-pay.

Or call 1-844-437-6611.

In the maker’s words

“Patients pay $0 per copay per dose per 12-month calendar period.”

“For cash-paying patients, the program will cover $150 per prescription up to $1,800 per calendar year.”

From the maker’s offer on heronconnect.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Cinvanti itself, from the same company, sold without the brand name, and usually for less. For now Cinvanti is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Preventing nausea and vomiting from cancer treatment

What the FDA label says

CINVANTI is a substance P/neurokinin-1 (NK1) receptor antagonist, indicated in adults, in combination with other antiemetic agents, for the prevention of:

acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin as a single-dose regimen.
delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC) as a single-dose regimen.
nausea and vomiting associated with initial and repeat courses of MEC as a 3-day regimen.

Limitations of Use:

CINVANTI has not been studied for treatment of established nausea and vomiting.

Source: the FDA label for Cinvanti (Heron Therapeutics, Inc.), April 1, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to the clinic’s billing office.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/cinvanti/